相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A 10% liquid immunoglobulin preparation for intravenous use (Privigen®) in paediatric patients with primary immunodeficiencies and hypersensitivity to IVIG
J. Lozano-Blasco et al.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2014)
Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America
A. Condino-Neto et al.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2014)
Quantification Of The Wear-Off Effect Towards The End Of The Intravenous Immunoglobulin Infusion Interval: Pooled Data Analysis
John-Philip Lawo et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
The Utility Of Anti-Pneumococcal Antibody Measurement In Patients With Primary Immunodeficiency Receiving Immunoglobulin
Stephen Jolles et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Subcutaneous immunoglobulin therapy given by subcutaneous rapid push vs infusion pump: a retrospective analysis
Ralph S. Shapiro
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2013)
Illustrative cases on individualizing immunoglobulin therapy in primary immunodeficiency disease
Vincent R. Bonagura
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2013)
Subcutaneous immunoglobulin (16 or 20%) therapy in obese patients with primary immunodeficiency: a retrospective analysis of administration by infusion pump or subcutaneous rapid push
R. Shapiro
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Subcutaneous immunoglobulin replacement therapy: the European experience
Helen Chapel et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Subcutaneous Immunoglobulin for Primary and Secondary Immunodeficiencies: an Evidence-Based Review
Jenny Lingman-Framme et al.
DRUGS (2013)
Pharmacoeconomic advantages of subcutaneous versus intravenous immunoglobulin treatment in a Canadian pediatric center
Thierry Ducruet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Experience with a 20% Subcutaneous Immunoglobulin (Hizentra®) in Children with Primary Immunodeficiency Diseases - A Single-Center Review
Rebecca Gregory et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Controversies in IgG replacement therapy in patients with antibody deficiency diseases
Erwin W. Gelfand et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Immunologists' Attitudes On Wear-off Effects of IgG Replacement Therapy for Primary Immunodeficiency Disease (PIDD) Patients
Mark Ballow et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Home Care Use of Intravenous and Subcutaneous Immunoglobulin for Primary Immunodeficiency in the United States
Faith Huang et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Comparative Study of Subcutaneous Versus Intravenous IgG Replacement Therapy in Pediatric Patients with Primary Immunodeficiency Diseases: A Multicenter Study in Argentina
Liliana Bezrodnik et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics
Ralph S. Shapiro
PEDIATRIC ALLERGY AND IMMUNOLOGY (2013)
Pharmacokinetic Modeling and Simulation of Biweekly Subcutaneous Immunoglobulin Dosing in Primary Immunodeficiency
Cornelia B. Landersdorfer et al.
POSTGRADUATE MEDICINE (2013)
Economic benefits of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency
A. Martin et al.
TRANSFUSION MEDICINE (2013)
Adverse Effects of Human Immunoglobulin Therapy
E. Richard Stiehm
TRANSFUSION MEDICINE REVIEWS (2013)
The Variable in Common Variable Immunodeficiency: A Disease of Complex Phenotypes
Stephen Jolles
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2013)
Importance of Ancillary Supplies for Subcutaneous Immunoglobulin Infusion Management of the Local Infusion Site
Carla Duff et al.
JOURNAL OF INFUSION NURSING (2013)
Comparison of American and European practices in the management of patients with primary immunodeficiencies
H. S. Hernandez-Trujillo et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy
J. S. Orange et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Bioavailability of IgG Administered by the Subcutaneous Route
M. Berger et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency
Richard L. Wasserman et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology
Jordan S. Orange et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Efficacy, Safety and Pharmacokinetics of a Novel Subcutaneous Immunoglobulin, Evogam®, in Primary Immunodeficiency
Marianne B. Empson et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Home therapy with subcutaneous immunoglobulins for patients with primary immunodeficiency diseases
Elie Haddad et al.
TRANSFUSION AND APHERESIS SCIENCE (2012)
Subcutaneous immunoglobulin replacement therapy with Hizentra®, the first 20% SCIG preparation: a Practical approach
S. Jolles et al.
ADVANCES IN THERAPY (2011)
Pharmacokinetics of Subcutaneous IgPro20 in Patients with Primary Immunodeficiency
Richard L. Wasserman et al.
CLINICAL PHARMACOKINETICS (2011)
Choices in IgG replacement therapy for primary immune deficiency diseases: subcutaneous IgG vs. intravenous IgG and selecting an optimal dose
Melvin Berger
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Subcutaneous Immunoglobulin Replacement Therapy in Infants and Children with Primary Immunodeficiencies
J. A. Church et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency
Michael Borte et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Efficacy and Safety of Subcutaneous VivaglobinA® Replacement Therapy in Previously Untreated Patients with Primary Immunodeficiency: A Prospective, Multicenter Study
Michael Borte et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Safety and Efficacy of Home-Based Subcutaneous Immunoglobulin G in Elderly Patients with Primary Immunodeficiency Diseases
Mark R. Stein et al.
POSTGRADUATE MEDICINE (2011)
The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions
A. GARDULF et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies A working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology
Pierre L. Yong et al.
CLINICAL IMMUNOLOGY (2010)
Association of FcRn expression with lung abnormalities and IVIG catabolism in patients with common variable immunodeficiency
T. Freiberger et al.
CLINICAL IMMUNOLOGY (2010)
Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies
Jordan S. Orange et al.
CLINICAL IMMUNOLOGY (2010)
Infection outcomes in patients with common variable immunodeficiency disorders: Relationship to immunoglobulin therapy over 22 years
Mary Lucas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Tolerability of a New 10% Liquid Immunoglobulin for Intravenous Use, PrivigenA (R), at Different Infusion Rates
John W. Sleasman et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency
John B. Hagan et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Subcutaneous Immunoglobulin Therapy by Rapid Push is Preferred to Infusion by Pump: A Retrospective Analysis
Ralph Shapiro
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency
Richard L. Wasserman et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies
R. Gustafson et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Prognostic factors for health-related quality of life in adults and children with primary antibody deficiencies receiving SCIG home therapy
A. Gardulf et al.
CLINICAL IMMUNOLOGY (2008)
Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency
Melvin Berger
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2008)
Pharmacokinetics of Immunoglobulin Administered via Intravenous or Subcutaneous Routes
Francisco A. Bonilla
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2008)
Biologic IgG level in primary immunodeficiency disease: The IgG level that protects against recurrent infection
Vincent R. Bonagura et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Quality of life and health-care resource utilization among children with primary immunodeficiency receiving home treatment with subcutaneous human immunoglobulin
Anders Fasth et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2008)
Common variable immunodeficiency: a new look at an old disease
Miguel A. Park et al.
LANCET (2008)
Safety and efficacy of subcutaneous human immunoglobulin in children with primary immunodeficiency
Anders Fasth et al.
ACTA PAEDIATRICA (2007)
Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration
Gregory I. Frost
EXPERT OPINION ON DRUG DELIVERY (2007)
Immunoglobulin treatment for primary antibody deficiencies - Advantages of the subcutaneous route
Ann Gardulf
BIODRUGS (2007)
Replacement IgG therapy and self-therapy at home improve the health-related quality of life in patients with primary antibody deficiencies
Ann Gardulf et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology
JS Orange et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies -: A prospective, multi-national study
Ann Gardulf et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home
U Nicolay et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home
A Gardulf et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency - A randomized double-blind trial
CM Roifman et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Express subcutaneous IgG infusions: Decreased time of delivery with maintained safety
S Hansen et al.
CLINICAL IMMUNOLOGY (2002)
Rapid subcutaneous IgG replacement therapy at home for pregnant immunodeficient women
A Gardulf et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2001)
The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy
HM Chapel et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2000)
分享论文
